- David Griggs, Ph.D.
Dr. Griggs is a scientific expert in the field of integrin biology with over 20 years of experience managing drug research programs at large pharmaceutical companies (Searle, Pharmacia, and Pfizer) and in a university-based translational pharmacology center (the Center for World Health and Medicine at Saint Louis University). More »
He has led teams that designed and implemented nearly two dozen in vitro integrin functional assays as well as diverse in vivo studies to evaluate efficacy, pharmacology, and safety of RGD-binding integrin antagonists.« Less
- Peter Ruminski, M.S.
Mr. Ruminski is an accomplished pharmaceutical scientist with over 34 years of research experience and a recognized expert in the design of RGD-binding integrin antagonists. More »
He possesses a strong medicinal chemistry and molecular biology background and has extensive experience in the discovery of drug candidates and in advancing them into human clinical trials. He previously held positions at Monsanto, Searle, Pharmacia, and Pfizer and most recently served as adjunct professor in the department of Biochemistry and Molecular Biology and as Executive Director of the Center for World Health and Medicine at Saint Louis University.« Less